AIDS 2020

 

Accepted Abstracts & Presentations> AIDS 2020

 

The IMPAACT Network proudly presented seven abstracts at the AIDS 2020 conference: three as oral presentations and four as poster presentations. Studies presented included P1025, P1093, P1078/TB APPRISE, P1104s, IMPAACT 2002, and ACTG5300/IMPAACT 2003 (PHOENIx).

Presentations will be added as we are given permissions and/or access from IAS.

>> Download the IMPAACT at AIDS 2020 Full Listing <<

 

23rd International AIDS Conference, 6-10 July 2020

Protocol Title Authors Presentation Type, Time
IMPAACT P1093

 

Plasma Exposure-Viral Load Response Analysis for Dolutegravir in Children with HIV-1: Results from IMPAACT P1093

 

Singh R, Acosta E, Buchanan A, Green J, Brothers C, Wiznia A, Alvero C, Farhad M, Bartlett M, Popson S, Townley E, Hazra R, George K, Ruel T, Vavro C, Baker M, and the P1093 Team

Oral presentation
IMPAACT P1078

 

Risk Factors for Hepatotoxicity in HIV-infected Women Receiving Isoniazid preventive Therapy in Pregnancy and Postpartum

 

Gupta A, Aaron L, Theron G, McCarthy K, Bradford S, Chipato T,
Vhembo T, Stranix-Chibanda L, Onyango-Makumbi C, Masheto GR, Chakhtoura N, Jean-Phillippe P, Browning R, Sterling T, Weinberg A, Montepiedra G, for the IMPAACT P1078 Study Team

Oral presentation


PHOENIx


Prevalence and Incidence of Tuberculosis Infection and Disease Among Household Contacts Exposed to Rrifampin-resistant/Multidrug resistant Tuberculosis (RR/MDR-TB)

 

Gupta A, Wu X, Kim S, Naini L, Hughes M, Dawson R, Gaikwad S,  Sanchez J, Mendoza A, Smith B, Shah S, Hesseling A, Churchyard G, Swindells S for the ACTG/IMPAACT PHOENIx feasibility study team

Oral presentation


IMPAACT 2002


Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression among Youth Living with HIV in the United States

 

Brown L.K., Chernoff M, Kennard B.D., Emslie G.J., Shapiro D.E., Lypen K, Buisson S, Weinberg A, Whiteley L.B., Traite S, Krotje C, Harriff L, and Townley E for the IMPAACT 2002 team

Poster Presentation


IMPAACT P1104s


Associations of Nevirapine-based ART Regimens with Neuropsychological Outcomes in HIV-positive Children


Fairlie L, Chernoff M, Cotton MF, Bwakura-Dangarembizi M, Violari A, Familiar-Lopez I, Barlow-Mosha L, Kamthunzi P, McCarthy K,
Jean-Philippe P, Laughton B, Palumbo PE, Boivin MJ


Poster presentation

IMPAACT P1093

 

Twenty-Four-Week Safety, Tolerability and Efficacy of Dolutegravir Dispersible Tablets in Children 4 Weeks to <6 years Old With HIV: Results From IMPAACT P1093

 

Ruel T, Farhad M, Alvero C, Acosta E, Singh R, George K, Montanez N, Popson S, Bartlett M, Dayton D, Anthony P, Buchanan A, Brothers C, Vavro C, Koech L, Vhembo T, Hazra R, Townley E, Wiznia A, and the P1093 Team

Poster presentation


IMPAACT P1025


Hospitalization is Associated with Seroconversion to Parainfluenza and Respiratory Syncytial Virus in HIV-Exposed, Uninfected Infants Born in the United States


Smith C, Huo Y, Patel K, Getters K, Van Dyke R, Weinberg A,
IMPAACT P1025 and PHACS SMARTT study teams


Poster presentation

 

← Publications Home

 

 

 

 

Funded by the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Mental Health of the US National Institutes of Health, US Department of Health and Human Services.